4.6 Article

Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis

期刊

PLOS ONE
卷 16, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0244766

关键词

-

资金

  1. National Multiple Sclerosis Society (NMSS)
  2. Novartis Save Neuron Grant
  3. Sydney Eye Hospital foundation grant
  4. Sydney University Medical foundation

向作者/读者索取更多资源

The study presents a new method to analyze diffusivity within chronic MS lesions, revealing a correlation between axonal loss and diffusivity changes, indicating that demyelination and axonal loss independently contribute to the increase of RD in lesions.
We describe a new single-streamline based approach to analyse diffusivity within chronic MS lesions. We used the proposed method to examine diffusivity profiles in 30 patients with relapsing multiple sclerosis and observed a significant increase of both RD and AD within the lesion core (0.38+/-0.09 mu m(2)/ms and 0.30+/-0.12 mu m(2)/ms respectively, p<0.0001 for both) that gradually and symmetrically diminished away from the lesion. T1-hypointensity derived axonal loss correlated highly with Delta AD (r = 0.82, p<0.0001), but moderately with Delta RD (r = 0.60, p<0.0001). Furthermore, the trendline of the Delta AD vs axonal loss intersected both axes at zero indicating close agreement between two measures in assessing the degree of axonal loss. Conversely, the trendline of the Delta RD function demonstrated a high positive value at the zero level of axonal loss, suggesting that even lesions with preserved axonal content exhibit a significant increase of RD. There was also a significant negative correlation between the level of preferential RD increase (Delta RD-Delta AD) in the lesion core and the degree of axonal damage (r = -0.62, p<0.001), indicating that Delta RD dominates in cases with milder axonal loss. Modelling diffusivity changes in the core of chronic MS lesions based on the direct proportionality of Delta AD with axonal loss and the proposed dual nature of Delta RD yielded results that were strikingly similar to the experimental data. Evaluation of lesions in a sizable cohort of MS patients using the proposed method supports the use of Delta AD as a marker of axonal loss; and the notion that demyelination and axonal loss independently contribute to the increase of RD in chronic MS lesions. The work highlights the importance of selecting appropriate patient cohorts for clinical trials of pro-remyelinating and neuroprotective therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据